Benzimate is the lead compound selected from a series of compounds known as benzimidazoles. The anti-cancer and anti-viral activity of the benzimidazoles was originally investigated by the Proctor & Gamble Company (P & G) beginning in the 1990’s.
Anti-cancer drug developer AmpliMed Corp. announced a clinical benefit rate of 44.4 percent for its lead drug candidate Amplimexon.
New research supported in part by the National Institute on Drug Abuse (NIDA), National Institutes of Health, shows that prevention programs conducted in middle school can reduce methamphetamine abuse among rural adolescents years later. Because methamphetamine addiction leads to problems with social interactions and a wide range of medical conditions, research into early interventions such as this is critical to protecting the nation?s youth. The paper is published in the September issue of Archives of Pediatrics and Adolescent Medicine.
The hormone progestin, as a component of hormone replacement therapy (HRT) following menopause, appears to exacerbate deficits in hearing sensitivity and auditory speech processing, according to a research team at the Rochester School of Medicine and Dentistry in New York.
Estrens did build bone, but might also raise cancer risks, study finds. Experimental osteoporosis drugs called estrens do not perform as well as researchers had hoped, new animal studies suggest.
Study Finds No Increased Risk of Lymphoma or Tumors Associated with Anti-TNF Therapy Over Methotrexate Use Among Rheumatoid Arthritis Patients. Patients with rheumatoid arthritis (RA), an autoimmune, inflammatory disease marked by progressive joint and organ damage, face a high risk of developing cancer.
But the benefits were relatively small, indicating need for newer medications. Two different drug regimens for difficult-to-treat major depression — one a combination of two newer drugs and the other a single, older drug — were comparable in putting people with depression in remission.
Bipolar disorder costs twice as much in lost productivity as major depressive disorder, a study funded by the National Institutes of Health?s (NIH) National Institute of Mental Health (NIMH) has found. Each U.S. worker with bipolar disorder averaged 65.5 lost workdays in a year, compared to 27.2 for major depression. Even though major depression is more than six times as prevalent, bipolar disorder costs the U.S. workplace nearly half as much ? a disproportionately high $14.1 billion annually.
No one wants to be called ?obese?. You are counted to be obese because you have just extra pound of fat on your body. Obesity must have placed you into several embarrassing moment. I know you have tried a lot of weight loss drugs and some other weight losing products, but you couldn?t find any result. But you don?t need to humiliate much more because weight loss drugs are here to cure obesity.
The Merck and Co. drug Fosamax does a better job at preventing bone deterioration than Vitamin D for people using steroids to treat arthritis, suggests a study released Wednesday.